Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Maternal Taurine Supplementation Enhances Thermogenesis of Newborn Lambs by Promoting Brown Adipogenesis.

Li Y., Huo J., Yu S., Xiang Y., Feng Y., Jiang Z.

Animal Study on Face & Skin, published in FASEB J (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
FASEB J (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41139244
DOI
10.1096/fj.202502140RR

Abstract (original English)

This study aimed to investigate the effect of maternal taurine (Tau) supplementation during gestation on the development of brown adipose tissue (BAT) and the thermogenesis of offspring lambs. Sixty ewes were randomly divided into three groups and daily supplemented with 0 g (control group), 2 g (low Tau), and 4 g (high Tau) during the gestation period after artificial insemination. The body surface temperature of newborn lambs was measured daily. At 15 days of age, lambs were slaughtered for sample collection. Compared to the control group, lambs in the high-Tau group exhibited higher body temperatures (p < 0.05). Maternal Tau-treated lambs had higher expression of UCP1 (p < 0.05), a greater number of multilocular brown adipocytes, and increased mitochondrial count in the BAT (p < 0.05). Additionally, there were higher copies of mitochondrial DNA and expression of mitochondrial proteins in the maternal Tau-treated lambs (p < 0.05). Enhanced AMPK and ULK1 activation (p < 0.05) were also observed in the BAT of 15-day-old lambs. Further analysis of the effects of Tau on BAT stromal vascular fraction (SVF) cells revealed that Tau treatment upregulated UCP1 during the brown adipogenic differentiation stages (p < 0.05). Consistently, Tau treatment upregulated mitochondrial biogenesis genes and increased the number of mitochondria (p < 0.05). Tau treatment significantly upregulated P

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsThermogenesisTaurineFemaleAdipose Tissue, BrownSheepAdipogenesisAnimals, NewbornPregnancyDietary Supplements

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research